Iovance Biotherapeutics, Inc. IOVA Intangible assets — net
Intangible assets — net at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s intangible assets — net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s intangible assets — net?
- Iovance Biotherapeutics, Inc. (IOVA) reported intangible assets — net of $269.1M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s intangible assets — net changed year-over-year?
- Iovance Biotherapeutics, Inc.'s intangible assets — net decreased by 5.7% year-over-year, from $285.36M to $269.1M.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s intangible assets — net?
- Over 2 years (2023 to 2025), Iovance Biotherapeutics, Inc.'s intangible assets — net has grown at a 10.4% compound annual growth rate (CAGR), from $229.26M to $279.32M.